Valuation models
price $927.89 · as of Nov 2, 2026
DCF · Perpetuity growth · 5yused972.19 – 1,623.151,213.6324% undervaluedDCF · Perpetuity growth · 10y1,017.99 – 1,712.241,275.1727% undervaluedDCF · EBITDA exit · 5y1,109.28 – 1,204.531,155.6020% undervaluedDCF · EBITDA exit · 10y1,134.44 – 1,321.731,223.5324% undervaluedP/E · peers1,128.09 – 1,207.461,159.9420% undervaluedP/E · own history742.93 – 1,088.26952.193% undervaluedPEG—876.636% overvaluedEV/EBITDA · peers875.55 – 1,061.851,041.7811% undervaluedEV/Revenue · peers671.94 – 1,213.131,089.4915% undervaluedEarnings power value447.33 – 666.23532.9474% overvaluedDividend discount96.59 – 245.58167.78453% overvaluedWall St. consensus target—870.007% aboveCost of capital (WACC)—6.89%—
DCF · Perpetuity growth · 5y leads for profitable growth — positive operating income and three years of positive free cash flow. How the headline model is chosen.
Model value · DCF · Perpetuity growth · 5y
1,213.63
Regeneron closed at $927.89 — undervalued by 24% vs model.
972.19the model's range1,623.15
DCF · Perpetuity growth · 5y leads for profitable growth — positive operating income and three years of positive free cash flow. From a five-year discounted cash flow.
Other models
167.78 – 1,275.17
Wall St. target
870.00 7% above
Below model, 1y
30 of 30 days
How it is valued
Valued asProfitable Growth
Low/slowing growth (~5% recent)High profitability (31% net margin)Moderately volatile earnings
Model estimates for research reference only, not investment advice. Every model rests on assumptions that may not match what happens; how each model works is in the manual.